Public Companies
Payton Nyquvest, CEO of Numinus, Sits in the Investor Hotseat on September 29th
Numinus ($NUMI) CEO, Payton Nyquvest, joins the Investor Hotseat to field hot questions from host, Dustin Robinson of Iter Investments. Numinus empowers…

Numinus ($NUMI) CEO, Payton Nyquvest, joins the Investor Hotseat to field hot questions from host, Dustin Robinson of Iter Investments.
Numinus empowers people to heal and be well through developing and delivering innovative mental health care and access to safe, evidence-based psychedelic-assisted therapies. Payton deeply understands the psychedelic industry from its infancy, driven by life-saving personal experiences with multiple therapeutic modalities. Additionally, Payton has deep business leadership experience, particularly in the finance sector, and is a recognized innovator and visionary in mental health care.
Can Payton handle the Hotseat?
As always, this will be a live event. You’ll be able to stream it from the Psychedelic Invest website, YouTube, LinkedIn, Facebook, Twitch, and Twitter. If you miss it, though, don’t worry. It will be recorded and available across those channels after the event.
If you’d like to attend the live event, you can set a reminder on Youtube or LinkedIn. Or, you can come back to the Hotseat livestream page at the time of the event.
To RSVP to ensure your spot, please fill out the form below.
A Transcription Will Be Available Following the Event

-
Public Companies20 hours ago
atai Life Sciences Completes Phase 1 Study of Oral DMT
-
Public Companies19 hours ago
Jupiter Acquisition Files Investor Presentation on Filament Health Deal
-
Psilocybin19 hours ago
Atai, Cybin Give Positive Psychedelic Drug Study Updates
-
Psilocybin18 hours ago
Cybin Completes Dosing in Phase 2 Study of CYB003 for the Treatment of Major Depressive Disorder